{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T08:50:06Z","timestamp":1770972606010,"version":"3.50.1"},"reference-count":35,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,12]]},"DOI":"10.1097\/hjh.0b013e3283311ba1","type":"journal-article","created":{"date-parts":[[2009,11,17]],"date-time":"2009-11-17T08:23:09Z","timestamp":1258446189000},"page":"2444-2451","source":"Crossref","is-referenced-by-count":112,"title":["Stimulation of AT2 receptor exerts beneficial effects in stroke-prone rats: focus on renal damage"],"prefix":"10.1097","volume":"27","author":[{"given":"Paolo","family":"Gelosa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alice","family":"Pignieri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lars","family":"F\u00e4ndriks","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc","family":"de Gasparo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anders","family":"Hallberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristina","family":"Banfi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Castiglioni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucia","family":"Turolo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Uliano","family":"Guerrini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena","family":"Tremoli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luigi","family":"Sironi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20-20210208","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/S0031-6997(24)01458-3","article-title":"International union of pharmacology. XXIII. The angiotensin II receptors","volume":"52","author":"de Gasparo","year":"2000","journal-title":"Pharmacol Rev"},{"key":"R2-20-20210208","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1080\/08037050500230227","article-title":"Angiotensin receptor blockers: therapeutic targets and cardiovascular protection","volume":"14","author":"Ruilope","year":"2005","journal-title":"Blood Press"},{"key":"R3-20-20210208","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0167-0115(99)00023-3","article-title":"The AT2 receptor: fact, fancy and fantasy","volume":"81","author":"de Gasparo","year":"1999","journal-title":"Regul Pept"},{"key":"R4-20-20210208","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1161\/01.HYP.0000149105.75125.2a","article-title":"Angiotensin subtype-2 receptors inhibit renin biosynthesis and angiotensin II formation","volume":"45","author":"Siragy","year":"2005","journal-title":"Hypertension"},{"key":"R5-20-20210208","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1016\/j.peptides.2005.03.010","article-title":"The AT2 receptor: a matter of love and hate","volume":"26","author":"Steckelings","year":"2005","journal-title":"Peptides"},{"key":"R6-20-20210208","first-page":"1364","article-title":"Angiotensin II type II receptor. Does it have a role in the normal or diseased kidney?","volume":"9","author":"Ardaillou","year":"1994","journal-title":"Nephrol Dial Transplant"},{"key":"R7-20-20210208","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0031-6997(24)01434-0","article-title":"Molecular and cellular mechanisms of angiotensin II-mediated cardiovascular and renal diseases","volume":"52","author":"Kim","year":"2000","journal-title":"Pharmacol Rev"},{"key":"R8-20-20210208","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1093\/ndt\/gfi265","article-title":"Angiotensin II: a key factor in the inflammatory and fibrotic response in kidney diseases","volume":"21","author":"Ruiz-Ortega","year":"2006","journal-title":"Nephrol Dial Transplant"},{"key":"R9-20-20210208","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1097\/01.ASN.0000130564.75008.F5","article-title":"Angiotensin II, via AT1 and AT2 receptors and NF-kappaB pathway, regulates the inflammatory response in unilateral ureteral obstruction","volume":"15","author":"Esteban","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"R10-20-20210208","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1172\/JCI119615","article-title":"Angiotensin II stimulates expression of the chemokine RANTES in rat glomerular endothelial cells. Role of the angiotensin type 2 receptor","volume":"100","author":"Wolf","year":"1997","journal-title":"J Clin Invest"},{"key":"R11-20-20210208","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1046\/j.1523-1755.2002.00365.x","article-title":"Angiotensin II activates nuclear transcription factor-kappaB through AT1 and AT2 receptors","volume":"61","author":"Wolf","year":"2002","journal-title":"Kidney Int"},{"key":"R12-20-20210208","doi-asserted-by":"crossref","first-page":"2716","DOI":"10.1161\/hc4601.099404","article-title":"Roles of angiotensin II type 2 receptor stimulation associated with selective angiotensin II type 1 receptor blockade with valsartan in the improvement of inflammation-induced vascular injury","volume":"104","author":"Wu","year":"2001","journal-title":"Circulation"},{"key":"R13-20-20210208","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1210\/me.2003-0053","article-title":"Regulation of inhibitory protein-kappaB and monocyte chemoattractant protein-1 by angiotensin II type 2 receptor-activated Src homology protein tyrosine phosphatase-1 in fetal vascular smooth muscle cells","volume":"18","author":"Wu","year":"2004","journal-title":"Mol Endocrinol"},{"key":"R14-20-20210208","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1152\/physiolgenomics.2000.2.1.13","article-title":"Inflammation influences vascular remodeling through AT2 receptor expression and signaling","volume":"2","author":"Akishita","year":"2000","journal-title":"Physiol Genomics"},{"key":"R15-20-20210208","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.atherosclerosis.2007.11.006","article-title":"Over-expression of angiotensin II type 2 receptor (agtr2) reduces atherogenesis and modulates LOX-1, endothelial nitric oxide synthase and heme-oxygenase-1 expression","volume":"199","author":"Hu","year":"2008","journal-title":"Atherosclerosis"},{"key":"R16-20-20210208","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1161\/01.STR.32.3.753","article-title":"Acute-phase proteins before cerebral ischemia in stroke-prone rats: identification by proteomics","volume":"32","author":"Sironi","year":"2001","journal-title":"Stroke"},{"key":"R17-20-20210208","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1124\/jpet.104.072066","article-title":"Anti-inflammatory effects of AT1 receptor blockade provide end-organ protection in stroke-prone rats independently from blood pressure fall","volume":"311","author":"Sironi","year":"2004","journal-title":"J Pharmacol Exp Ther"},{"key":"R18-20-20210208","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1161\/01.HYP.33.2.613","article-title":"Recent progress in angiotensin II type 2 receptor research in the cardiovascular system","volume":"33","author":"Horiuchi","year":"1999","journal-title":"Hypertension"},{"key":"R19-20-20210208","doi-asserted-by":"crossref","first-page":"5995","DOI":"10.1021\/jm049715t","article-title":"Design, synthesis, and biological evaluation of the first selective nonpeptide AT2 receptor agonist","volume":"47","author":"Wan","year":"2004","journal-title":"J Med Chem"},{"key":"R20-20-20210208","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/0167-0115(93)90244-3","article-title":"Agonistic and antagonistic properties of angiotensin analogs at the AT2 receptor in PC12W cells","volume":"44","author":"Brechler","year":"1993","journal-title":"Regul Pept"},{"key":"R21-20-20210208","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0014-2999(94)90153-8","article-title":"Renal actions of the angiotensin AT2 receptor ligands CGP 42112 and PD 123319 after blockade of the renin-angiotensin system","volume":"259","author":"Macari","year":"1994","journal-title":"Eur J Pharmacol"},{"key":"R22-20-20210208","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.2353\/ajpath.2007.060882","article-title":"Rosuvastatin treatment prevents progressive kidney inflammation and fibrosis instroke-prone rats","volume":"170","author":"Gianella","year":"2007","journal-title":"Am J Pathol"},{"key":"R23-20-20210208","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.tem.2005.02.006","article-title":"Plasma renin and aldosterone measurements in low renin hypertensive states","volume":"16","author":"Sealey","year":"2005","journal-title":"Trends Endocrinol Metab"},{"key":"R24-20-20210208","doi-asserted-by":"crossref","first-page":"925","DOI":"10.3109\/10641969709083196","article-title":"Antihypertensive drugs in the stroke-prone spontaneously hypertensive rat","volume":"19","author":"Richer","year":"1997","journal-title":"Clin Exp Hypertens"},{"key":"R25-20-20210208","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1038\/sj.bjp.0704398","article-title":"Effects of amlodipine and lacidipine on cardiac remodelling and renin production in salt-loaded stroke-prone hypertensive rats","volume":"134","author":"Kyselovic","year":"2001","journal-title":"Br J Pharmacol"},{"key":"R26-20-20210208","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1161\/STROKEAHA.108.531509","article-title":"Angiotensin AT2 receptor stimulation causes neuroprotection in a conscious rat model of stroke","volume":"40","author":"McCarthy","year":"2009","journal-title":"Stroke"},{"key":"R27-20-20210208","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1097\/01.hjh.0000251902.85675.7e","article-title":"Angiotensin II\/AT2 receptor-induced vasodilation in stroke-prone spontaneously hypertensive rats involves nitric oxide and cGMP-dependent protein kinase","volume":"24","author":"Savoia","year":"2006","journal-title":"J Hypertens"},{"key":"R30-20-20210208","doi-asserted-by":"crossref","first-page":"2523","DOI":"10.1161\/CIRCULATIONAHA.108.784868","article-title":"Angiotensin II type 2 receptor stimulation: a novel option of therapeutic interference with the renin-angiotensin system in myocardial infarction?","volume":"118","author":"Kaschina","year":"2008","journal-title":"Circulation"},{"key":"R31-20-20210208","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.amjmed.2003.09.034","article-title":"The renin-angiotensin-aldosterone system and the kidney: effects on kidney disease","volume":"116","author":"Brewster","year":"2004","journal-title":"Am J Med"},{"key":"R32-20-20210208","doi-asserted-by":"crossref","first-page":"R1461","DOI":"10.1152\/ajpregu.00014.2007","article-title":"NO and cGMP mediate angiotensin AT2 receptor-induced renal renin inhibition in young rats","volume":"293","author":"Siragy","year":"2007","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"R33-20-20210208","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1291\/hypres.26.915","article-title":"Angiotensin II type 2 receptor inhibits prorenin processing in juxtaglomerular cells","volume":"26","author":"Ichihara","year":"2003","journal-title":"Hypertens Res"},{"key":"R34-20-20210208","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1291\/hypres.26.737","article-title":"A newly developed angiotensin II type 1 receptor antagonist, CS866, promotes regression of cardiac hypertrophy by reducing integrin beta1 expression","volume":"26","author":"Jia","year":"2003","journal-title":"Hypertens Res"},{"key":"R35-20-20210208","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1161\/01.HYP.31.6.1272","article-title":"Salt induces vascular AT1 receptor overexpression in vitro and in vivo","volume":"31","author":"Nickenig","year":"1998","journal-title":"Hypertension"},{"key":"R36-20-20210208","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1161\/01.HYP.0000161990.98383.ad","article-title":"High-salt diet inhibits expression of angiotensin type 2 receptor in resistance arteries","volume":"45","author":"Gonzalez","year":"2005","journal-title":"Hypertension"},{"key":"R37-20-20210208","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1161\/HYPERTENSIONAHA.108.114058","article-title":"Enhanced angiotensin II type 2 receptor mechanisms mediate decreases in arterial pressure attributable to chronic low-dose angiotensin II in female rats","volume":"52","author":"Sampson","year":"2008","journal-title":"Hypertension"}],"container-title":["Journal of Hypertension"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00004872-200912000-00020","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,13]],"date-time":"2025-02-13T08:16:49Z","timestamp":1739434609000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00004872-200912000-00020"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,12]]},"references-count":35,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.1097\/hjh.0b013e3283311ba1","relation":{},"ISSN":["0263-6352"],"issn-type":[{"value":"0263-6352","type":"print"}],"subject":[],"published":{"date-parts":[[2009,12]]}}}